Cdx1 and c-Myc Foster the Initiation of Transdifferentiation of the Normal Esophageal Squamous Epithelium toward Barrett's Esophagus
Open Access
- 27 October 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (10), e3534
- https://doi.org/10.1371/journal.pone.0003534
Abstract
Barrett's esophagus is a premalignant condition whereby the normal stratified squamous esophageal epithelium undergoes a transdifferentiation program resulting in a simple columnar epithelium reminiscent of the small intestine. These changes are typically associated with the stratified squamous epithelium chronically exposed to acid and bile salts as a result of gastroesophageal reflux disease (GERD). Despite this well-defined epidemiologic association between acid reflux and Barrett's esophagus, the genetic changes that induce this transdifferentiation process in esophageal keratinocytes have remained undefined. To begin to identify the genetic changes responsible for transdifferentiaiton in Barrett's esophagus, we performed a microarray analysis of normal esophageal, Barrett's esophagus and small intestinal biopsy specimens to identify candidate signaling pathways and transcription factors that may be involved. Through this screen we identified the Cdx1 homeodomain transcription factor and the c-myc pathway as possible candidates. Cdx1 and c-myc were then tested for their ability to induce transdifferentiation in immortalized human esophageal keratinocytes using organotypic culturing methods. Analyses of these cultures reveal that c-myc and cdx1 cooperate to induce mucin production and changes in keratin expression that are observed in the epithelium of Barrett's esophagus. These data demonstrate the ability of Cdx1 and c-myc to initiate the earliest stages of transdifferentiation of esophageal keratinocytes toward a cell fate characteristic of Barrett's esophagus.Keywords
This publication has 48 references indexed in Scilit:
- Risk of Mortality and Cancer Incidence in Barrett's EsophagusCancer Epidemiology, Biomarkers & Prevention, 2007
- Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinomaInternational Journal of Cancer, 2007
- Molecular defense mechanisms of Barrett’s metaplasia estimated by an integrative genomicsJournal of Molecular Medicine, 2007
- Molecular basis of Barrett's oesophagus and oesophageal adenocarcinomaGut, 2006
- Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot studyGastrointestinal Endoscopy, 2006
- Barrett's Esophagus and Its Progression to AdenocarcinomaJournal of the National Comprehensive Cancer Network, 2006
- Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesisOncogene, 2006
- Natural selection in neoplastic progression of Barrett's esophagusSeminars in Cancer Biology, 2005
- Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal DifferentiationCancer Research, 2005
- Gene expression profiles in esophageal adenocarcinomaThe Annals of Thoracic Surgery, 2004